BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gluud M, Pallesen EMH, Buus TB, Gjerdrum LMR, Lindahl LM, Kamstrup MR, Bzorek M, Danielsen M, Bech R, Monteiro MN, Blümel E, Willerslev-Olsen A, Lykkebo-Valløe A, Vadivel CK, Krejsgaard T, Bonefeld CM, Geisler C, Becker JC, Koralov SB, Iversen L, Litman T, Woetmann A, Ødum N. Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma. Blood 2023;141:180-93. [PMID: 36122387 DOI: 10.1182/blood.2022016690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fay CJ, Awh KC, LeBoeuf NR, Larocca CA. Harnessing the immune system in the treatment of cutaneous T cell lymphomas. Front Oncol 2022;12:1071171. [PMID: 36713518 DOI: 10.3389/fonc.2022.1071171] [Reference Citation Analysis]
2 Steinhoff M, Alam M, Ahmad A, Uddin S, Buddenkotte J. Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes. Semin Cancer Biol 2022;87:98-116. [PMID: 36372325 DOI: 10.1016/j.semcancer.2022.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]